Tocqueville Asset Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Tocqueville Asset Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,033	Closed	-$412K	–	933
2015 Q4	$412K	Sell	2,033 -2,990	-60%	-$535K	0.01%	710
2015 Q3	$730K	Buy	5,023 +300	+6%	+$55.1K	0.01%	618
2015 Q2	$1M	Buy	4,723 +1,498	+46%	+$367K	0.01%	573
2015 Q1	$747K	Buy	3,225 +1,825	+130%	+$441K	0.01%	634
2014 Q4	$323K	Buy	+1,400	New	+$300K	﹤0.01%	793

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tocqueville Asset Management's BLCM Position: Q1 2016 in Review

Tocqueville Asset Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2016, closing a stake of 2,033 shares — an estimated $412K sold.

Tocqueville Asset Management first reported a position in BLCM in Q4 2014 and held it in 5 quarters. The position peaked at $1M in Q2 2015. 78 funds tracked by Wall St. Rank hold BLCM as of Q1 2016.

Tocqueville Asset Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Tocqueville Asset Management sold 2,033 Bellicum Pharmaceuticals, Inc. shares in Q1 2016, an estimated $412K.
Tocqueville Asset Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
Tocqueville Asset Management's Bellicum Pharmaceuticals, Inc. position peaked at $1M in Q2 2015.
78 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2016.

Based on Tocqueville Asset Management's 13F filing for Q1 2016, filed 29 Apr 2016.